Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients

NCT07321613 · clinicaltrials.gov ↗

COMPLETED

Status

545

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Cancer (HCC)

Interventions

DRUG: Thalidomide (50mg)
DRUG: carmofur
DRUG: compound mylabris capsule
PROCEDURE: TACE

Sponsor

Shanghai Zhongshan Hospital